When high-risk GBA and LRRK2 variants were removed from the PRS calculation, and when all pathogenic or high-risk variant carriers were excluded from our model, PD patients with a higher genetic risk burden showed greater improvement in depressive symptoms after DBS than those with a lower PRS. This evidence concerns the gene LRRK2 and Parkinson disease.